Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipid lowering versus revascularization: an idea whose time (for testing) has come

J S Forrester1, P K Shah

  • 1Cedars-Sinai Medical Center, Los Angeles, Calif 90048-1865, USA. forrester@csmc.edu

Circulation
|August 19, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A protocol for the Development of Core Outcome Sets for Endodontic Treatment modalities (COSET): an international consensus process.

Trials·2021
Same author

Comparison of two case difficulty assessment methods on cohorts of undergraduate dental students - a multi-centre study.

International endodontic journal·2020
Same author

Preferred Reporting Items for study Designs in Endodontology (PRIDE): guiding authors to identify and correct reporting deficiencies in their manuscripts prior to peer review.

International endodontic journal·2020
Same author

PRICE 2020 guidelines for reporting case reports in Endodontics: explanation and elaboration.

International endodontic journal·2020
Same author

PRICE 2020 guidelines for reporting case reports in Endodontics: a consensus-based development.

International endodontic journal·2020
Same author

MIIRetCam (Make In India Retina Camera) assisted retinal imaging in paediatric patients: Useful, artefacts, learning curve.

Journal francais d'ophtalmologie·2019

Revascularization does not prevent myocardial infarction in stable coronary artery disease (CAD). Lipid-lowering therapy shows promise for preventing heart attacks and improving survival in CAD patients.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Preventive Medicine

Background:

  • Stable coronary artery disease (CAD) management often involves revascularization, aiming to prevent myocardial infarction (MI).
  • Current revascularization strategies target angiographically significant stenoses, but evidence suggests these do not prevent MI.
  • Most MIs occur at sites without severe stenosis, indicating a gap in current therapeutic targets.

Purpose of the Study:

  • To evaluate the effectiveness of revascularization versus lipid-lowering therapy in preventing myocardial infarction in stable CAD.
  • To explore the underlying pathology of coronary atherosclerosis contributing to MI.
  • To determine the optimal therapeutic strategies for managing CAD and preventing MI.

Main Methods:

  • Review of evidence on revascularization (coronary artery bypass graft surgery, percutaneous transluminal coronary angioplasty) in stable CAD.

Related Experiment Videos

  • Analysis of angiographic and thallium study data regarding lesion severity and ischemia.
  • Comparison of the impact of revascularization and lipid-lowering therapy on MI rates.

    • Main Results:

    • Revascularization does not prevent myocardial infarction in patients with stable CAD.
    • Myocardial infarctions frequently occur at non-stenotic or mildly stenotic sites.
    • Lipid-lowering therapy reduces myocardial infarction rates by approximately 30% over 5 years.

    Conclusions:

    • Revascularization therapies do not address the lesions that cause myocardial infarction.
    • Lipid-lowering therapy appears more effective than revascularization for preventing MI and improving long-term survival in CAD.
    • Further research is needed to define the roles of lipid-lowering and revascularization in CAD management.